Dr. Sumon Agarwala, MD (he/him) is an Endocrinologist in Collegeville, PA with over 16 years of experience. What is your opinion of Dr. Sumon Agarwala, MD? Rate this provider below so other people can make informed decision.
Over 16 Years of Experience
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Sumon Agarwala, MD has received over $1,223,683 which includes payments from the following companies:
$722,893.35 from sanofi-aventis U.S. LLC
$360,474.94 from AstraZeneca Pharmaceuticals LP
$45,515.65 from Novo Nordisk Inc
$40,736.12 from LILLY USA, LLC
$23,376.53 from Boehringer Ingelheim Pharmaceuticals, Inc.
$12,081.42 from Medtronic MiniMed, Inc.
$6,770.97 from AbbVie, Inc.
$2,360.41 from Janssen Pharmaceuticals, Inc
$2,348.04 from GlaxoSmithKline, LLC.
$1,869.49 from E.R. Squibb & Sons, L.L.C.
$1,012.50 from Allergan Inc.
$855.89 from Tandem Diabetes Care, Inc.
$787.50 from Becton, Dickinson and Company
$780.00 from Novo Nordisk AS
$482.30 from Valeritas, Inc.
$279.00 from GENZYME CORPORATION
$190.63 from Shire North American Group Inc
$173.68 from INSULET CORPORATION
$102.49 from Boston Scientific Corporation
$83.38 from Abbott Laboratories
Payments received by Dr. Sumon Agarwala, MD were from the following categories:
$975,276.01 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!